Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Journal of Medicinal Chemistry|November 8, 2017
Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-LinkersStephen J Gregson, Luke A Masterson, Binqing Wei, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Linker Immolation Determines Cell Killing Activity of Disulfide-Linked Pyrrolobenzodiazepine Antibody-Drug ConjugatesDonglu Zhang, Thomas H Pillow, Yong Ma, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant TumorsLeanna R Staben, Shang-Fan Yu, Jinhua Chen, et al.
Molecular Cancer Therapeutics|March 16, 2021
Calicheamicin Antibody-Drug Conjugates with Improved PropertiesBreanna S Vollmar, Chris Frantz, Melissa M Schutten, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Nature Chemistry|November 23, 2016
Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugatesLeanna R Staben, Stefan G Koenig, Sophie M Lehar, et al.
Pageof 18